This announcement is a separate document:
卫信康：西藏卫信康医药股份有限公司2022年半年度报告摘要
Wei Xinkang: Summary of the 2022 semi-annual report of Tibet Weixinkang Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated